UO Oncologia , Spedali Civili di Brescia
Welcome,         Profile    Billing    Logout  
 1 Trial 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ferrari, Vittorio
POINT, NCT04825990 / 2013-001185-41: Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer

Recruiting
2
30
Europe
Pembrolizumab, olaparib
Gruppo Oncologico del Nord-Ovest
Nasopharyngeal Carcinoma
09/25
03/28
RAGAZ, NCT06604364: Virtual Reality for Reducing Anxiety in Pediatric Orthopedic Surgery

Recruiting
N/A
50
Europe
hypno VR
Istituto Ortopedico Rizzoli
Virtual Reality
01/25
06/26

Download Options